Accuracy of subcutaneous continuous glucose monitor during perioperative period

Accuracy of subcutaneous continuous glucose monitor during perioperative period - Accuracy of subcutaneous continuous glucose monitor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013338

Enrollment

Registered

2014-03-06

Start date

2014-03-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma, Pancreas tumor, Esophageal cancer

Interventions

Subcutaneous continuous glucose monitor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Schedule operated patient of liver, pancreas and esophagus

Exclusion criteria

Exclusion criteria: Patients who was not used an artificial pancreas for perioperative glucose control

Design outcomes

Primary

Measure	Time frame
Difference between glucose measured by subcutaneous continuous glucose monitor and glucose measured by artificial pancreas.	—

Countries

Japan

Contacts

Public ContactTomoaki Yatabe

Kochi Medical School Anesthesiology

yatabe@kochi-u.ac.jp088-880-2471

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026